TECHNEGAS KIT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Technegas Kit, and when can generic versions of Technegas Kit launch?
Technegas Kit is a drug marketed by Cyclomedica and is included in one NDA.
The generic ingredient in TECHNEGAS KIT is technetium tc-99m labeled carbon. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m labeled carbon profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TECHNEGAS KIT?
- What are the global sales for TECHNEGAS KIT?
- What is Average Wholesale Price for TECHNEGAS KIT?
Summary for TECHNEGAS KIT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 2 |
DailyMed Link: | TECHNEGAS KIT at DailyMed |
![TECHNEGAS KIT drug patent expirations Drug patent expirations by year for TECHNEGAS KIT](/p/graph/s/t/TECHNEGAS_KIT-patent-expirations.png)
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for TECHNEGAS KIT
Generic Entry Date for TECHNEGAS KIT*:
Constraining patent/regulatory exclusivity:
NEW PRODUCT NDA:
Dosage:
AEROSOL;INHALATION |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for TECHNEGAS KIT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Cyclomedica Australia PTY Limited | Phase 3 |
US Patents and Regulatory Information for TECHNEGAS KIT
TECHNEGAS KIT is protected by zero US patents and one FDA Regulatory Exclusivity.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of TECHNEGAS KIT is ⤷ Sign Up.
This potential generic entry date is based on NEW PRODUCT.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
FDA Regulatory Exclusivity protecting TECHNEGAS KIT
NEW PRODUCT
Exclusivity Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cyclomedica | TECHNEGAS KIT | technetium tc-99m labeled carbon | AEROSOL;INHALATION | 022335-001 | Sep 29, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |